Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms.

A new partnership between Cronos Group, a Canadian vertically integrated cannabis company, and Ginkgo Bioworks, a Massachusetts-based bioengineering specialist, will see Ginkgo modify the DNA of yeast so that it can produce cannabinoids in a fermentation process.

They include cannabidiolic acid (CBDA), a substance naturally present in the hemp plant, which is then turned into cannabidiol (CBD) when its chemical composition is altered through heating.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us